Although our study fails to identify the subtype or recurrence specific biomarkers, we discovered that gene fusion with EYA1 is the most common fusion across all subtypes of meningioma, indicating EYA1 fusion is likely an early event in tumorigenesis in meningioma. This evidence concerns the gene EYA1 and meningioma.